All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @morethanmyweight on TikTok · 50s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @morethanmyweight's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Alright, I'm gonna be honest. I love the way that Zebound works. It has great results. It makes me feel like I'm not hungry.
  2. 0:09But...
  3. 0:11It does have one side effect that I'm not particularly excited about.
  4. 0:16And let me just say that after you take the shot within the first day,
  5. 0:23my
  6. 0:25ass
  7. 0:26chose violence.
  8. 0:31I was driving to work and I had to stop twice.
  9. 0:36And oh my god. So I know that it causes constipation for some people.
  10. 0:44But it's the complete opposite for me.
  11. 0:47We chose violence today.

@morethanmyweight's Zepbound side effect claim, fact-checked

Yelena | Health, Hockey, Humor

TikTok creator

346.5K viewsWatch on TikTok

Quick answer

Tirzepatide (Zepbound) produces gastrointestinal side effects, including diarrhea, in a substantial portion of users, with the SURMOUNT-1 trial reporting diarrhea in up to 23% of participants at the 15mg dose. The creator's description of acute diarrhea within the first day after injection is consistent with known GI effects of dual GIP/GLP-1 receptor agonism, which can alter gut motility in either direction depending on the individual. Most GI symptoms are most severe early in treatment or following dose escalation and tend to diminish over time.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded TirzepatideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Tirzepatide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @morethanmyweight's Zepbound side effect claim, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

Compounded Tirzepatide should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this tirzepatide video claims cluster

Best for searchers deciding whether tirzepatide claims are stronger, safer, or more relevant than semaglutide claims.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@morethanmyweight's Zepbound side effect claim, fact-checked" from Yelena | Health, Hockey, Humor. We read the clip as a GLP-1 social video fact-checks claim about Compounded Tirzepatide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Tirzepatide (Zepbound) produces gastrointestinal side effects, including diarrhea, in a substantial portion of users, with the SURMOUNT-1 trial reporting diarrhea in up to 23% of participants at the 15mg dose.

The reason this review is not generic is the source wording and the canonical claim label "glp1 the side effect tho zepbound." In this clip, the useful excerpt is: "Alright, I'm gonna be honest." That wording changes the review because it points to Compounded Tirzepatide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Tirzepatide Once Weekly for the Treatment of Obesity (2022), Continued Treatment With Tirzepatide for Maintenance of Weight Reduction (2024), and Tirzepatide for Obesity Treatment and Diabetes Prevention (2025), plus the creator's own wording. Compounded Tirzepatide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Both diarrhea and constipation are documented GI effects of tirzepatide.
People who land here are usually comparing the Compounded Tirzepatide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Tirzepatide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Tirzepatide (Zepbound) produces gastrointestinal side effects, including diarrhea, in a substantial portion of users, with the SURMOUNT-1 trial reporting diarrhea in up to 23% of participants at the 15mg dose.

FormBlends verdict

Compounded Tirzepatide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Tirzepatide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Tirzepatide (Zepbound) produces gastrointestinal side effects, including diarrhea, in a substantial portion of users, with the SURMOUNT-1 trial reporting diarrhea in up to 23% of participants at the 15mg dose. The creator's description of acute diarrhea within the first day after injection is consistent with known GI effects of dual GIP/GLP-1 receptor agonism, which can alter gut motility in either direction depending on the individual. Most GI symptoms are most severe early in treatment or following dose escalation and tend to diminish over time.
  • SURMOUNT-1 (Jastreboff et al., 2022, NEJM) reported diarrhea in up to 23% of tirzepatide users at the 15mg dose, making it one of the most common side effects, not a rare one.
  • Both diarrhea and constipation are documented GI effects of tirzepatide. Individual gut response to altered motility varies, and neither outcome is more 'correct' than the other.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Tirzepatide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Tirzepatide guide, cost path, safety notes, and provider review before acting.

Review Compounded Tirzepatide

What You'll Learn

  • SURMOUNT-1 (Jastreboff et al., 2022, NEJM) reported diarrhea in up to 23% of tirzepatide users at the 15mg dose, making it one of the most common side effects, not a rare one.
  • Both diarrhea and constipation are documented GI effects of tirzepatide. Individual gut response to altered motility varies, and neither outcome is more 'correct' than the other.
  • GI symptoms are most severe in the first days after injection or a dose increase, which matches the creator's experience of urgency within 24 hours of their shot.
  • GI side effects are the leading reason people reduce dose or discontinue GLP-1 therapy, per Rubino et al. (2022, NEJM), making honest public discussion of these effects genuinely useful.
  • Practical steps that may reduce GI severity include eating smaller portions, avoiding high-fat meals around injection time, and maintaining hydration, though individual results differ.
  • If diarrhea is severe, persistent, or causes signs of dehydration, it warrants direct contact with a prescribing clinician, not just reassurance from social media.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @morethanmyweight actually say?

The creator said Zepbound works well for suppressing hunger but caused an urgent GI problem: "my ass chose violence." Specifically, they described having to stop twice while driving to work after taking their injection. They also noted they know it "causes constipation for some people" but their experience was the opposite. No dosage claims, no cure claims. Just a raw, honest account of a real side effect.

This is the kind of first-person GLP-1 content that floods TikTok: anecdotal, relatable, and often more useful than a sanitized drug pamphlet. But anecdote is not data, so let's look at what the clinical record actually says about tirzepatide and gastrointestinal effects.

Does the science back this up?

Yes, and pretty decisively. Diarrhea is one of the most commonly reported side effects of tirzepatide, and the clinical trial data does not bury this. The SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) reported diarrhea in roughly 17-23% of tirzepatide participants depending on dose, compared to about 9% in the placebo group. That is not a rare outlier experience.

The mechanism makes sense physiologically. Tirzepatide activates both GIP and GLP-1 receptors. GLP-1 receptor agonism slows gastric emptying, which is why some people get constipation. But the gut is not a simple on/off switch. Altered motility can swing either direction, especially early in treatment or after a dose increase. The creator did not explain the mechanism, but their lived experience lines up with what the trials show.

  • Diarrhea incidence in SURMOUNT-1: up to 23% at the 15mg dose
  • Nausea was even more common, affecting over 30% of participants
  • Most GI side effects peaked early and tapered over weeks

What did they get wrong (or right)?

They got the core observation right. Diarrhea is a documented, common side effect of Zepbound, and the creator's framing that it is "the complete opposite" of constipation is accurate. Both outcomes exist in different patients, and neither one is fabricated.

Where the video leaves something on the table is context. Saying "it causes constipation for some people" is correct, but the data shows diarrhea is actually more frequently reported than constipation in the tirzepatide trials. Constipation is real, but it is not the dominant GI complaint in the clinical literature. So the framing that their experience is unusual or surprising is slightly off. Diarrhea, especially in the first day or two after injection, is actually one of the more expected GI responses.

The creator also did not mention that timing relative to meals, hydration, and dose level all influence GI response. That context would have been useful, but this is a TikTok, not a package insert. The creator was not trying to be comprehensive. They were being honest about their body, which has genuine value.

What should you actually know?

If you are on tirzepatide or semaglutide and experiencing urgent diarrhea, you are not doing something wrong and you are not alone. GI side effects are the primary reason people reduce or discontinue GLP-1 therapy, according to Rubino et al. (2022, NEJM) following semaglutide discontinuation analysis.

A few things worth knowing:

  • GI effects tend to be worst in the first few days after an injection or a dose increase, not necessarily ongoing
  • Eating smaller meals, avoiding high-fat foods, and staying hydrated can reduce severity for some people
  • If diarrhea is severe, persistent, or accompanied by signs of dehydration, that warrants a conversation with a prescriber, not just a TikTok
  • Constipation and diarrhea are both documented. Individual response varies. Neither response means the medication is failing

The creator's candid video probably helps more people feel normal about their experience than it misleads. That counts for something.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Yelena | Health, Hockey, Humor · TikTok creator

346.5K views on this video

The side effect tho. #zepbound

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about surmount-1 (jastreboff et al., 2022, nejm) reported diarrhea in up?

SURMOUNT-1 (Jastreboff et al., 2022, NEJM) reported diarrhea in up to 23% of tirzepatide users at the 15mg dose, making it one of the most common side effects, not a rare one.

What does the video say about both diarrhea?

Both diarrhea and constipation are documented GI effects of tirzepatide. Individual gut response to altered motility varies, and neither outcome is more 'correct' than the other.

What does the video say about gi symptoms?

GI symptoms are most severe in the first days after injection or a dose increase, which matches the creator's experience of urgency within 24 hours of their shot.

What does the video say about gi side effects?

GI side effects are the leading reason people reduce dose or discontinue GLP-1 therapy, per Rubino et al. (2022, NEJM), making honest public discussion of these effects genuinely useful.

What does the video say about practical steps?

Practical steps that may reduce GI severity include eating smaller portions, avoiding high-fat meals around injection time, and maintaining hydration, though individual results differ.

What does the video say about if diarrhea?

If diarrhea is severe, persistent, or causes signs of dehydration, it warrants direct contact with a prescribing clinician, not just reassurance from social media.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Yelena | Health, Hockey, Humor, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.